V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000720 | 230000423 | 1.87 | 87.5 | Not known (9) | 2014-05-17 | 2014-05-17 | IRINOTECAN + MDG | 99 | N | 230011433 | CARBOPLATIN + ETOPOSIDE |
| 230000721 | 230000424 | 1.69 | 69 | Curative (C) | 2018-03-10 | 2018-03-10 | EC | N | Y | 230011556 | CAPECITABINE + TRASTUZUMAB |
| 230000722 | 230000424 | 1.73 | 88.5 | Palliative (P) | 2014-06-07 | 2014-07-08 | CAPECITABINE + OXALIPLATIN | N | N | 230011556 | SORAFENIB |
| 230000723 | 230001523 | 1.55 | 62 | Adjuvant (A) | 2018-12-11 | 2018-12-11 | Oxaliplatin + Modified de Gramont | 02 | N | 230011728 | SORAFENIB |
| 230000724 | 230000425 | 1.72 | 90.4 | Adjuvant (A) | 2016-05-09 | 2016-05-26 | CAPECITABINE + OXALIPLATIN | 02 | N | 230011766 | CETUXIMAB + RT |
| 230000725 | 230000426 | 1.7 | 57.4 | Palliative (P) | 2017-10-10 | 2017-10-14 | Capecitabine | 02 | N | 230011799 | DOXORUBICIN |
| 230000726 | 230000427 | 0 | 0 | Adjuvant (A) | 2018-02-07 | 2018-02-22 | EOF | N | N | 230011834 | SORAFENIB |
| 230000727 | 230000428 | null | null | Palliative (P) | 2016-12-26 | 2016-12-29 | Irinotecan + Modified De Gramont | 2 | N | 230011851 | CHOP R |
| 230000728 | 230000429 | 1.65 | 74.1 | Palliative (P) | 2019-01-05 | 2019-01-06 | TEMOZOLOMIDE | 02 | null | 230011967 | CARBOPLATIN + ETOPOSIDE |
| 230000729 | 230001210 | 1.64 | 90.2 | Palliative (P) | 2016-11-02 | 2016-11-02 | Cisplatin | 2 | N | 230012015 | CISPLATIN + DOXORUBICIN |
| 230000730 | 230001524 | 1.65 | 85 | Palliative (P) | 2016-09-03 | 2016-10-02 | VANDETANIB | N | N | 230012070 | CAPECITABINE + OXALIPLATIN |
| 230000731 | 230000430 | 1.7 | 61 | Adjuvant (A) | 2014-08-30 | 2014-09-26 | FEC 60 or 75 | N | N | 230012086 | ESHAP |
| 230000732 | 230000431 | 1.86 | 65 | null | 2017-09-06 | 2017-09-13 | Cisplatin + Doxorubicin | N | null | 230012155 | GEMCARBO |
| 230000733 | 230000432 | 1.5 | 71 | Disease modification (D) | 2018-04-13 | 2018-04-13 | Capecitabine | N | N | 230012213 | SORAFENIB |
| 230000734 | 230001211 | 1.49 | null | Neo-adjuvant (N) | 2015-09-14 | 2015-09-24 | Capecitabine + Oxaliplatin 21day | 02 | N | 230012245 | CAPECITABINE + OXALIPLATIN |
| 230000735 | 230000433 | 1.8 | null | Palliative (P) | 2017-01-07 | 2017-01-08 | VANDETANIB | null | Y | 230012315 | ESPAC TRIAL |
| 230000736 | 230000434 | 1.69 | 83.3 | Palliative (P) | 2018-09-26 | 2018-10-17 | Rituximab | N | N | 230012339 | VANDETANIB |
| 230000737 | 230000434 | 1.63 | 108.3 | Adjuvant (A) | 2017-12-09 | 2018-01-03 | CAPECITABINE + OXALIPLATIN | N | N | 230012339 | CAPECITABINE + MITOMYCIN + RT |
| 230000738 | 230000435 | 1.87 | 76.9 | Palliative (P) | 2019-01-13 | 2019-01-27 | Bevacizumab + Cape + Oxali 14day | N | N | 230012388 | VANDETANIB |
| 230000739 | 230001213 | 1.72 | 56 | Palliative (P) | 2016-01-09 | 2016-01-19 | CAPECITABINE + MITOMYCIN + RT | 99 | N | 230012389 | CAPECITABINE + OXALIPLATIN |
| 230000740 | 230000436 | 1.78 | 71.2 | Curative (C) | 2014-07-14 | 2014-07-19 | ESPAC-4 TRIAL | 02 | N | 230012421 | CARBOPLATIN + PACLITAXEL |
| 230000741 | 230000436 | 1.62 | 60.55 | Palliative (P) | 2017-01-18 | 2017-01-18 | CARBOPLATIN | 02 | N | 230012421 | VANDETANIB |
| 230000742 | 230000437 | 1.62 | 64.3 | Neo-adjuvant (N) | 2016-05-02 | 2016-05-02 | Capecitabine + Oxaliplatin 21day | 02 | Y | 230012498 | CISPLATIN + GEMCITABINE |
| 230000743 | 230000437 | 1.72 | 83 | Adjuvant (A) | 2015-01-04 | 2015-01-24 | BCG Intravesical | N | Y | 230012498 | VANDETANIB |
| 230000744 | 230000438 | 0 | 82 | Adjuvant (A) | 2014-12-07 | 2014-12-07 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 230012547 | CISPLATIN + DOXORUBICIN |
| 230000745 | 230000439 | 1.81 | 0 | Disease modification (D) | 2016-07-20 | 2016-07-31 | Sorafenib | N | N | 230012583 | SORAFENIB |
| 230000746 | 230000440 | 1.75 | 82.8 | Curative (C) | 2017-05-05 | 2017-05-20 | Cisplatin + Doxorubicin | 2 | N | 230012605 | CHOP R |
| 230000747 | 230001216 | 1.77 | 60.7 | Neo-adjuvant (N) | 2017-03-19 | 2017-03-23 | Capecitabine 35days + RT | 2 | Y | 230012664 | CAPECITABINE |
| 230000748 | 230000441 | 1.61 | 76.2 | Neo-adjuvant (N) | 2018-09-27 | 2018-09-27 | Cisplatin + Pemetrexed | N | N | 230012767 | SORAFENIB |
| 230000749 | 230000442 | 1.68 | 68.1 | Adjuvant (A) | null | 2015-01-02 | Oxaliplatin + Modified de Gramont | null | null | 230012797 | CETUXIMAB + RT |
| 230000750 | 230000443 | 1.72 | 69.9 | Adjuvant (A) | 2012-12-05 | 2016-02-16 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230012808 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 230000751 | 230000444 | null | 79.5 | null | 2014-02-20 | 2014-03-05 | Carboplatin + Pemetrexed | N | null | 230012832 | RITUXIMAB |
| 230000752 | 230000444 | 1.8 | null | Palliative (P) | 2017-07-04 | 2017-07-14 | Carboplatin + Pemetrexed | N | N | 230012832 | PLATO TRIAL |
| 230000753 | 230000445 | 1.74 | 73.6 | Adjuvant (A) | 2017-02-16 | 2017-02-16 | R Chlorambucil | N | null | 230012968 | CARBOPLATIN |
| 230000754 | 230000446 | 1.7 | 84.5 | Adjuvant (A) | 2017-01-17 | 2017-02-13 | Trial Unspecified | N | Y | 230012985 | CARBOPLATIN |
| 230000755 | 230000447 | 1.59 | 68.1 | Adjuvant (A) | 2016-10-23 | 2016-10-27 | Oxaliplatin + Modified de Gramont | 02 | null | 230013000 | CHOP R |
| 230000756 | 230001218 | 1.71 | 80 | Adjuvant (A) | 2014-12-29 | 2014-12-29 | Capecitabine + Oxaliplatin 21day | N | N | 230013058 | IRINOTECAN + MDG |
| 230000757 | 230001525 | 0 | 86.2 | Palliative (P) | 2018-04-24 | 2018-05-20 | Irinotecan + Modified De Gramont | N | N | 230013104 | CHOP R |
| 230000758 | 230000448 | 1.59 | 68 | Palliative (P) | 2017-11-29 | 2017-12-10 | Capecitabine | 02 | N | 230013127 | RUXOLITINIB |
| 230000759 | 230000448 | 1.61 | 67.4 | Adjuvant (A) | 2018-04-10 | 2018-04-13 | Carboplatin + Etoposide IV 3 day | 02 | N | 230013127 | CISPLATIN |
| 230000760 | 230000449 | null | 102 | Not known (9) | 2018-05-17 | 2018-05-18 | Capecitabine + Oxaliplatin 14day | 2 | null | 230013180 | CAPECITABINE |
| 230000761 | 230000449 | 1.78 | 54 | Curative (C) | 2015-04-25 | 2015-05-01 | Temozolomide + RT | null | null | 230013180 | CETUXIMAB + RT |
| 230000762 | 230000449 | null | 63.3 | null | 2018-02-25 | 2018-03-02 | FLUOROURACIL | N | null | 230013180 | CISPLATIN |
| 230000763 | 230000449 | 1.79 | 93.6 | Adjuvant (A) | 2018-04-05 | 2018-04-06 | CAPECITABINE + OXALIPLATIN | 2 | N | 230013180 | CARBOPLATIN + DOCETAXEL |
| 230000764 | 230000449 | 1.77 | 100.9 | Adjuvant (A) | null | 2017-08-24 | Capecitabine | N | N | 230013180 | CISPLATIN + PACLITAXEL |
| 230000765 | 230000449 | 1.54 | 82 | Adjuvant (A) | 2017-09-25 | 2017-09-25 | CARBOPLATIN | N | N | 230013180 | CARBOPLATIN + PACLITAXEL |
| 230000766 | 230000450 | 1.72 | 80 | Curative (C) | 2015-03-14 | 2015-03-14 | CAPECITABINE + MITOMYCIN + RT | N | N | 230013278 | CAPECITABINE + RT |
| 230000767 | 230000451 | 1.71 | 70 | Palliative (P) | 2018-04-20 | 2018-05-02 | Irinotecan + Modified De Gramont | 02 | N | 230013289 | BENDAMUSTINE + RITUXIMAB |
| 230000768 | 230000451 | 1.55 | 68.4 | Adjuvant (A) | 2016-07-03 | 2016-07-03 | Sorafenib | 2 | N | 230013289 | GEMCARBO |
| 230000769 | 230000451 | 1.6 | 75.3 | Palliative (P) | 2014-12-07 | 2015-01-07 | Capecitabine | N | N | 230013289 | CTD |